Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC33A1 | O00400 | 18/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9258787 | 0.86 | SLC33A1 (0.44) | SLC33A1 | |
| SCHEMBL9254999 | 0.84 | CYP1A2 (0.53) | SLC33A1USP2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL9258759 | 0.82 | SLC33A1 (0.44) | SLC33A1 | |
| SCHEMBL9254444 | 0.81 | SLC33A1 (0.48) | SLC33A1 | |
| SCHEMBL9256912 | 0.80 | SLC33A1 (0.46) | SLC33A1 | |
| SCHEMBL9253961 | 0.80 | SLC33A1 (0.46) | SLC33A1 | |
| SCHEMBL8314256 | 0.80 | SLC33A1 (0.46) | SLC33A1 | |
| SCHEMBL9257779 | 0.80 | SLC33A1 (0.46) | SLC33A1 | |
| SCHEMBL9252542 | 0.80 | SLC33A1 (0.43) | SLC33A1 | |
| SCHEMBL9251377 | 0.80 | SLC33A1 (0.43) | SLC33A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5387747-A | Used in the treatment and prevention of cardiovascular diseases: hypertension, cardiac insufficiency and atherosclerosis | LABORATOIRES UPSA (FR) | 1995-02-07 | — | — | US | disclosed |